TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmapress Oy
Closing information (x1000 NOK)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover | 10,824 | 11,113 | 13,182 |
Financial expenses | 0 | ||
Earnings before taxes | 669 | 472 | 660 |
Total assets | 6,406 | 5,788 | 6,127 |
Current assets | 3,631 | 4,679 | 4,741 |
Current liabilities | 1,210 | 1,027 | 1,023 |
Equity capital | 5,186 | 4,761 | 5,095 |
- share capital | 295 | 273 | 287 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency | 81.0% | 82.3% | 83.2% |
Turnover per employee | |||
Profit as a percentage of turnover | 6.2% | 4.2% | 5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio | 300.1% | 455.6% | 463.4% |
Return on equity (ROE) | 12.9% | 9.9% | 13.0% |
Change turnover | -1,210 | -1,417 | -1,023 |
Change turnover % | -10% | -11% | -7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.